Drug and Diagnostic Test Notices
There is currently a national drug shortage of
National drug shortages that have resolved
- Trichloroacetic Acid (TCA) (Resolved May 11, 2022)
For information on all current and resolved drug shortages and discontinuations reported to the U.S. Food & Drug Administration (FDA), please visit the FDA’s Drug Shortages page.
Diagnostic Test Kit Availability Information
STI Diagnostic Test Kits and Laboratory Suppliespdf icon (September 8, 2020)
Chlamydia/Gonorrhea Diagnostic Test Kits
- Resolved- December 15, 2021
Manufacturers of chlamydia/gonorrhea diagnostic test kits are reporting to CDC that their STI diagnostic test supplies are readily available at normal levels. Several end users of chlamydia/gonorrhea diagnostic test kits including laboratories, and healthcare settings indicate that test kits can be ordered without limitations. CDC’s Division of STD Prevention will continue to monitor the availability of STI diagnostic testing supplies in the United States.
Treponema pallidum Particle Agglutination (TP-PA)
- Resolved – June 17, 2021
According to Fujirebio Diagnostics, Inc., the sole manufacturer of Treponema pallidum Particle Agglutination (TP-PA) diagnostic test kits in the United States, the SERODIA®-TP-PA kit is currently available. All backorders for this test kit were shipped to customers on June 17, 2021. Please notify your local health department if you encounter any challenges in procuring this product. For more information on the availability of TP-PA test kits, please visit the Fujirebio Diagnostics, Inc.external icon website, email Fujirebio customer service ordering at kits@fdi.com, or contact your assigned Fujirebio sales representative. CDC will continue to monitor the situation and provide updates as needed.
STI Drug Availability as of July 29, 2022
Download Printable PDF
[PDF - 255 KB]
Medications
| FDA Drug Shortage List | Availability | Manufacturers * |
|---|---|---|
| No |
|
|
| FDA Drug Shortage List | Availability | Manufacturers * |
|---|---|---|
| No |
|
|
| FDA Drug Shortage List | Availability | Manufacturers * |
|---|---|---|
| Yes (as of 1/21/2022) |
|
|
1 https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Cefixime%20Oral%20Capsules&st=c&tab=tabs-1
* source: https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm
| FDA Drug Shortage List | Availability | Manufacturers * |
|---|---|---|
| No |
|
|
2 250 mg/500 mg vials
* source: https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm
| FDA Drug Shortage List | Availability | Manufacturers * |
|---|---|---|
| No |
|
|
3 100 mg tablet/capsule
* source: https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm
| FDA Drug Shortage List | Availability | Manufacturers * |
|---|---|---|
| Yes (as of 7/6/2022) |
|
|
4 https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Erythromycin%20Ophthalmic%20Ointment%20&st=c&tab=tabs-1
* source: https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm
| FDA Drug Shortage List | Availability | Manufacturers * |
|---|---|---|
| Yes (as of 7/23/2021) |
|
|
| FDA Drug Shortage List | Availability | Manufacturers * |
|---|---|---|
| Yes (as of 2/22/2012) |
|
|
6 https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm
* source: https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm
| FDA Drug Shortage List | Availability | Manufacturers * |
|---|---|---|
| No |
|
|
7 500mg tablet
* source: https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm